News

On 11 November, TASS press office hosted a conference on implementation of quality innovations by pharmaceutical manufacturers of the Eurasian Economic Union and featuring the announcement of GxP-Profi 2022 international contest results. Pharmaceutical company Akrikhin ranked first among over 20 participants from Russia, EAEU, and other countries.

On 5–8 September 2022, Moscow hosted the 9th (28th) National Diabetes Congress With International Participation “Diabetes and Obesity: Non-Communicable Multidimensional Pandemics of the 21st Century” with Akrikhin making a significant contribution.

On 7–9 September 2022, the VII All-Russia GMP Conference was held in Irkutsk. Akrikhin is the annual partner of this event of great importance for all experts of the industry.

Normobact L became the 2022 brand of the year in the Biologically Active Dietary Supplement nomination according to the Russian pharmaceutical community

Following the results of Smartpharma Awards 2022, the drug products by Akrikhin were named among the winners of the nomination titled “Pharmacist Choice: INN-Generics that I Trust”.

On 26 May 2022, the Moscow Region Government House hosted Women’s Health Forum sponsored by the Moscow regional office of Women’s Union of Russia where Akrikhin introduced its top-grade medicinal drugs to medical industry professionals.

On May 17–18, St. Petersburg hosted the annual Russian Pharmaceutical Forum named after N.A. Semashko. The head of AKRIKHIN, Denis Chetverikov, spoke at the event that brought together key players in the pharmaceutical market of Russia.

Akrikhin has served as a partner of GxP Fest international festival for undergraduate and graduate students and faculty of pharmaceutical universities. The project is administered by the Eurasian Academy of Good Practices and is supported by the Ministry of Industry and Trade of the Russian Federation and Federal Budgetary Institution “State Institute of Drugs and Good Practices” under this Ministry.

Following the results of the expert voting at the XXII All-Russian Pharmaceutical Contest “Platinum Ounce”, Aquadetrim by JSC “Akrikhin” was awarded the prestigious “OTC Drug Product of the Year” award for the second year in a row.

Akrikhin participated in the annual Convention of Paediatricians of Russia that was held under the title “Actual Problems of Paediatrics”.

We want you to know that our company will continue its stable operation in the current situation.

On 26 and 27 January 2022, the IV All-Russian Conference titled “Import Substitution, Accessible Medical Care, and Equal Opportunities in Dermatology” supported by AKRIKHIN was held in Moscow.

The product line of the Phytolysin brand by Akrikhin has been supplemented with a new product — Phytolysin, capsules.

Akrikhin together with the Bystrumgel brand co-sponsored live broadcasts of men’s ice hockey matches featuring the Russian team.

To support independent educational projects and research in the field of medicine along with charity initiatives intended to improve patients’ health and education, Akrikhin is launching a grant and donation program.